Proliferative response of different human osteoblast-like cell models to proinflammatory cytokines

Pediatric Research

Volumn 48, Issue 2, 2000, Pages 163-168

  Harbour, M E ^a   Gregory, J W ^a   Jenkins, H R ^a   Evans, B A J ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BONE MARROW CELL; CELL LINE; CELL PROLIFERATION; CELL TYPE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ACTIVITY; DISEASE PREDISPOSITION; ENTERITIS; HUMAN; HUMAN CELL; INFLAMMATION; OSTEOBLAST; OSTEOPENIA; OSTEOSARCOMA CELL; PRIORITY JOURNAL; STEM CELL; STROMA CELL;

EID: 0033944515     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-200008000-00008     Document Type: Article

References (49)

1. Bone mineral density and nutritional status in children with inflammatory bowel disease
2. Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: A population based study
3. Metabolic bone assessment in patients with inflammatory bowel disease
4. A controlled study of bone mineral density in patients with inflammatory bowel disease
5. Osteopenia in Crohn's disease
6. Inflammatory bowel disease and predisposition to osteopenia
7. Bone mass aquisition during infancy, childhood and adolescence
8. Role of cytokines and platelet-activating factor in inflammatory bowel disease
9. Enhanced mucosal cytokine production in inflammatory bowel disease
10. Cellular and Molecular Immunology
11. Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease
12. High circulating concentrations of interleukin-6 in active Crohn's disease but not ulcerative colitis
13. Tumour necrosis factor and inflammatory bowel disease
14. Elevation of serum interleukin-6 but not serum-soluble interleukin-2 receptor in children with Crohn's disease
15. Role of interleukin-1 in inflammatory bowel disease: Enhanced production during active disease
16. Tumour necrosis factor alpha is not elevated in children with IBD
17. Extraintestinal considerations in inflammatory bowel disease
18. Differentiation of human bone marrow osteogenic stromal cells in vitro: Induction of the osteoblast phenotype by dexamethasone
19. Human interferon: Mass production in a newly established cell line, MG-63
20. Use of poly A RT-PCR coupled with subtractive hybridisation to isolate novel genes involved in osteogenesis
21. New colorimetric cytotoxicity assay for anticancer-drug screening
22. Substrates for cytochemical demonstration of enzyme activity. II. Some dihalo-3-indolyl phosphates and sulfates
23. A new approach using tissue alkaline phosphatase activity to identify early testicular cancer
24. Inhibition of TNF-induced apoptosis by NF-κB
25. Structure, regulation and function of NF-κB
26. AP-1 function and regulation
27. Inducible regulatory elements in the human cyclin D1 promoter
28. NF-κB-like factors mediate interleukin-1 induction of c-myc gene transcription in fibroblasts
29. Interaction of an NF-κB-like factor with a site upstream of the c-myc promoter
30. A novel NF-κB element within exon 1 of the murine c-myc gene
31. Induction of NF-κB DNA-binding activity during the G0-G1 transition in mouse fibroblasts
32. Transcriptional control of osteoblast growth and differentiation
33. Expression and functional role of nitric oxide synthase isoforms in human osteoblast-like cells
34. Interleukin-1β enhances and tumor necrosis factor-α inhibits bone morphogenetic protein-2-induced alkaline phosphatase activity in MC3T3-E1 osteoblastic cells
35. Formation and mineralization of extra-cellular matrix secreted by an immortal human osteoblastic cell line: Modulation by tumor necrosis factor-alpha
36. Involvement of interleukin 1 and tumour necrosis factor α as endogenous growth factors in human osteoblastic cells
37. Effects of interleukin-1 beta and tumour necrosis factor-alpha on osteoblastic expression of osteocalcin and mineralized extracellular matrix in vitro
38. Inflammatory cytokines regulate proliferation of cultured human osteoblasts
39. c-Myc induces cellular susceptibility to the cytotoxic action of TNF-alpha
40. Induction of TNF-sensitive cellular phenotype by c-Myc involves p53 and impaired NF-κB activation
41. Transducing signals of life and death
42. Inhibition of TNF-induced apoptosis by NF-κB
43. Apoptosis: Activate NF-κB or die?
44. An essential role for NF-κB in preventing TNF-alpha-induced cell death
45. The p53 tumour suppressor gene
46. Inactivation of p53 gene in human and murine osteosarcoma cells
47. Estrogen, cytokines and pathogenesis of postmenopausal osteoporosis
48. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors
49. Modulation of osteoblast differentiation and function by the new member of the tumor necrosis factor and receptor and ligand families